Biospecimens, and the data generated from them, remain the cornerstone of all therapeutic and diagnostic research and development. Several recent innovations have opened new doors for researchers to gain added benefit from the use of biospecimens in disease research. These innovations include advances in biomarker screening technologies and novel cell technologies like liquid biopsy, cell isolation, and immune cell phenotyping, and enhancements to analysis approaches, such as machine learning.
This series of articles published by Genetic Engineering & Biotechnology News shares best practices and leading-edge developments in their sourcing, utilization, and storage. We also take an in-depth look into the Biospecimen Solutions group at Precision for Medicine, a global CRO, and how that group is solving critical challenges related to the suitability, quality, and scalability of biospecimens. Leveraging a proven strategic sourcing approach, Precision for Medicine combines its extensive patient and clinician network with end-to-end logistics, specialized laboratory services, and clinical trial design and execution capabilities to enable fit-for-purpose biospecimen procurement and expedite research.